Blog

Detecting Illicit Fentanyl in Newborns
Joseph Jones, Ph.D., NRCC-TC, Chief Operating Officer at USDTL discusses the toxicology of fentanyl in newborn umbilical cord tissue followed by a brief Q&A.
What You’ll Learn
- The advantages of using umbilical cord tissue for newborn toxicology.
- Does hospital-administered fentanyl show as positive at the 500 pg/g cutoff?
- What trends are we seeing with fentanyl in umbilical cord at USDTL?
- And more…
If you sign in and attend live, you will receive a Certificate of Attendance following the Webinar!
A recording will be made available for all registrants.
- Forensic vs. Clinical Drug Testing: Why Flexibility Matters for Your Organization
- USDTL’s Integration and Partnership With CourtFact
- New Year, New Capabilities: Offering Forensic & Clinical Testing Options
- Weather Delay
- The Detection of Delta-9-tetrahydrocannabinol, Delta-8-tetrahydrocannabinol, Delta-10-tetrahydrocannabinol, and Cannabidiol in Hair Specimens
- Umbilical Cord Tissue Testing for Ketamine
- Drugs of Abuse: A DEA Resource Guide (2024)
- Beyond THC and CBD: Understanding New Cannabinoids
- February 2026 (1)
- January 2026 (3)
- October 2025 (1)
- July 2025 (3)
- May 2025 (2)
- April 2025 (2)

